These findings together suggest that elevated levels of TXNIP and Erk1/2 phosphorylation and decreased Akt activation collectively cause a resistance to proliferation inhibition and selection of resistant clones in HCC. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.